Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Powell Michael
Relationship:   10% Owner
City:   San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   21    
Direct Shares   22,645,475    

Indirect Shares

   6,181,468      
Direct Value   $17,584,142    

Indirect Value

   $148,315,620      
Total Shares   28,826,943      
Total Value   $165,899,762      


Seagen Inc $4,575,029 Molecular Templates, Inc. $2,064,809 Anesiva Inc $0 Paratek Pharmaceuticals Inc $96,365 Humanigen Inc $41 Aravive Inc $86,094 Aclaris Therapeutics, Inc. $2,701,586 Entasis Therapeutics Holdings Inc. $2,584,590 Nextcure, Inc. $0 Iterum Therapeutics Plc $1,839,771 Akouos, Inc. $0 Inozyme Pharma, Inc. $0 Bolt Biotherapeutics, Inc. $3,635,857 Vera Therapeutics, Inc. $0 Seagen Inc $4,575,029 Molecular Templates, Inc. $2,064,809 Anesiva Inc $0 Paratek Pharmaceuticals Inc $96,365 Humanigen Inc $41 Aravive Inc $86,094 Aclaris Therapeutics, Inc. $2,701,586 Entasis Therapeutics Holdings Inc. $2,584,590 Nextcure, Inc. $0 Iterum Therapeutics Plc $1,839,771 Akouos, Inc. $0 Inozyme Pharma, Inc. $0 Bolt Biotherapeutics, Inc. $3,635,857 Vera Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    2    

     Stock price went up :
    0   
    2    
     Stock price went down :
    1   
    0    
   
     Gain/Loss Ratio :
   -1.0   
   2.0   
     Percentage Gain/Loss :
   -63.7%
 32.1%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Seagen Inc SGEN Director 2004-12-16 20,001 2004-12-16 647,577    Premium*  
            Molecular Templates, Inc. MTEM Director 2005-03-08 3,440,201 2006-03-16 12,846    Premium*  
            Anesiva Inc ANSVQ Director, 10% Owner 2007-12-18 65 2007-12-18 4,906,973    Premium*  
            Paratek Pharmaceuticals Inc PRTK 10% Owner 2006-05-09 43,213 0    Premium*  
            Orexigen Therapeutics, Inc. OREX Director 2010-12-23 1 2010-12-23 0    Premium*  
            Trius Therapeutics Inc TSRX Director 2010-08-06 0 2012-03-26 9,302    Premium*  
            Humanigen Inc HGEN 10% Owner 2013-02-05 414,394 2013-02-05 0    Premium*  
            Ocera Therapeutics Inc OCRX Director 2016-07-29 0 2016-10-31 14,328    Premium*  
            Aravive Inc ARAV 10% Owner 2014-03-26 2,146,978 2014-03-26 0    Premium*  
            Hyperion Therapeutics Inc HPTX 10% Owner 2015-05-07 0 2014-06-04 0    Premium*  
            Aerie Pharmaceuticals Inc AERI 10% Owner 2014-07-10 0 2014-07-09 0    Premium*  
            Marinus Pharmaceuticals Inc MRNS 10% Owner 2014-08-05 0 2016-10-20 15,470    Premium*  
            Synlogic Inc SYBX Director 2015-10-05 0 2018-01-26 574,972    Premium*  
            Aclaris Therapeutics, Inc. ACRS 10% Owner 2015-10-13 2,289,480 2015-10-13 0    Premium*  
            Entasis Therapeutics Holdings Inc. ETTX 10% Owner 2018-09-28 1,180,178 2018-09-28 0    Premium*  
            Nextcure, Inc. NXTC 10% Owner 2019-11-15 2,671,856 2019-11-15 0    Premium*  
            Iterum Therapeutics Plc ITRM 10% Owner 2020-06-02 1,226,514 2020-06-01 0    Premium*  
            Akouos, Inc. AKUS 10% Owner 2020-06-30 1,515,073 2020-06-30 0    Premium*  
            Inozyme Pharma, Inc. INZY 10% Owner 2020-07-28 2,028,308 2020-07-28 0    Premium*  
            Bolt Biotherapeutics, Inc. BOLT 10% Owner 2021-02-09 2,754,437 2021-02-09 0    Premium*  
            Vera Therapeutics, Inc. VERA 10% Owner 2021-05-18 2,914,776 2021-05-18 0    Premium*  
* Premium Members only  

Records found :    126         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ACRS Aclaris Therapeutics, Inc... 10% Owner   –       –       •   2015-10-13 4 B $11.00 $4,499,990 D/D 409,090 2,289,480 2.45 -
ACRS Aclaris Therapeutics, Inc... 10% Owner   –       –       •   2015-10-13 4 A $0.00 $0 D/D 1,880,390 1,880,390 0 -
AERI Aerie Pharmaceuticals Inc 10% Owner   –       –       •   2014-07-09 4 S $24.00 $24,001,300 D/D (1,000,000) 1,566,657 0 -
AERI Aerie Pharmaceuticals Inc 10% Owner   –       –       •   2014-07-10 4 S $25.81 $207,030 D/D (8,022) 0 0 -
AKUS Akouos, Inc. 10% Owner   –       –       •   2020-06-30 4 B $17.00 $999,991 D/D 58,823 1,515,073 2.45 -
AKUS Akouos, Inc. 10% Owner   –       –       •   2020-06-30 4 A $0.00 $0 D/D 1,456,250 1,456,250 0 -
ANSVQ Anesiva Inc officerTitle   –       •      –    2005-12-15 3 IO $0.00 $0 I/I 0 26,249 -
ANSVQ Anesiva Inc officerTitle   –       •      –    2005-12-15 3 IO $0.00 $0 D/D 0 64 -
ANSVQ Anesiva Inc Director   –       •      –    2005-12-15 4/A A $0.00 $0 I/I 1,177,020 17,600 0 -
ANSVQ Anesiva Inc Director   –       •      –    2005-12-15 4 A $0.00 $0 I/I 1,176,843 17,601 0 -
ANSVQ Anesiva Inc Director   –       •      –    2006-08-15 4/A B $6.86 $7 D/D 1 65 2.31 -
ANSVQ Anesiva Inc Director   –       •      –    2006-08-15 4 B $6.86 $7 D/D 1 1 2.31 -
ANSVQ Anesiva Inc Director   –       •       •   2007-12-18 4 B $4.05 $15,000,001 I/I 3,703,704 3,703,704 2.25 -
ARAV Aravive Inc 10% Owner   –       –       •   2014-03-26 4 B $21.00 $1,260,000 D/D 60,000 2,146,978 2.45 -
ARAV Aravive Inc 10% Owner   –       –       •   2014-03-26 4 A $0.00 $0 D/D 2,086,978 2,086,978 0 -
BOLT Bolt Biotherapeutics, Inc... 10% Owner   –       –       •   2021-02-09 4 B $20.00 $9,000,000 D/D 450,000 2,754,437 2.45 %
BOLT Bolt Biotherapeutics, Inc... 10% Owner   –       –       •   2021-02-09 4 A $0.00 $0 D/D 2,304,437 2,304,437 0 -
ETTX Entasis Therapeutics Hold... 10% Owner   –       –       •   2018-09-28 4 B $15.00 $5,065,860 D/D 337,724 1,180,178 2.45 -
ETTX Entasis Therapeutics Hold... 10% Owner   –       –       •   2018-09-28 4 A $0.00 $0 D/D 817,692 842,454 0 -
HGEN Humanigen Inc 10% Owner   –       –       •   2013-02-05 4 A $0.00 $0 D/D 1,765,117 31,415 0 -
HPTX Hyperion Therapeutics Inc 10% Owner   –       –       •   2014-06-04 4 S $27.70 $11,571,592 D/D (417,747) 1,939,474 0 -
HPTX Hyperion Therapeutics Inc 10% Owner   –       –       •   2015-05-07 4 D $46.00 $89,215,804 D/D (1,939,474) 0 0 -
INZY Inozyme Pharma, Inc. 10% Owner   –       –       •   2020-07-28 4 A $0.00 $0 D/D 1,590,808 1,590,808 0 -
INZY Inozyme Pharma, Inc. 10% Owner   –       –       •   2020-07-28 4 B $16.00 $7,000,000 D/D 437,500 2,028,308 2.45 -
ITRM Iterum Therapeutics Plc 10% Owner   –       –       •   2020-06-01 4 S $1.69 $169,120 D/D (100,000) 1,626,514 0 %
  126  Records found
  1  2   3   4   5   6      
  Page 1 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us